Czech Republic
Czech Republic has 11 institutes in the EATRIS network, spanning over all 5 platforms: Biomarkers, ATMP & Biological, Imaging & Tracing, Small Molecules and Vaccines. The Czech node has been a partner in many projects such as EATRIS-Plus – the flagship project and for example EOSC-Life, where EATRIS-CZ contributed to development of open-access database Micha.
During the pandemic, National Director of Czech node, Dr Marian Hajduch (IMTM) became a national coordinator for SARS-CoV-2 testing and he led COVID-19 Laboratory Group (advisory body to the Ministry of Health of the Czech Republic). Members of this group were also representatives of other EATRIS-CZ institutes, namely CEITEC, CU, IOCB. Under his leadership, the group established full electronation/digitalisation of testing, increased capacity form 0 (March 2020) to 55.000 PCR tests and 35.000 antigen tests/day (December 2020). This activity resulted in number of recommendations or orders issued by the Czech Government and complex legislation around COVID-19 pandemic.
Central European Institute of Technology at Masaryk University (CEITEC)
Charles University
Institute of Experimental Medicine of the CAS
Institute of Macromolecular Chemistry of the CAS
Institute of Microbiology of the CAS
Institute of Organic Chemistry and Biochemistry of the CAS
International Clinical Research Centre of St. Anne’s University Hospital Brno
Nuclear Physics Institute of the CAS
Palacký University, Institute of Molecular and Translational Medicine (IMTM)
